RRM1 and cancer: Silencing RRM1 promotes the interaction of MDM2 and P53 while decreasing the binding of USP11 to p53, thereby stimulating the ubiquitination of p53, in turn leading to decreased expression of p21, which eventually induces ferroptosis through inhibition of GPX4 and results in cancer cell death.139